Honda merges motorcycle companies

Honda merges motorcycle companies

Honda Motor announced it is combining its Thai motorcycle manufacturing firms -- A.P. Honda Co, Thai Honda Manufacturing Co and HPD Co, which is a shareholding company -- to form a new company called Thai Honda Manufacturing Co.

The establishment of the new company became effective on March 31.

"This amalgamation will strengthen Honda motorcycle operations in Thailand, making the brand more responsive to customers and ready for future market needs," said Masayuki Igarashi, chief officer for regional operations (Asia & Oceania) at Honda Motor Co.

He said the new company will combine the strengths of each company and eliminate redundancies, while increasing speed and accuracy in the area of motorcycle production.

Shigeto Kimura, former president of A.P. Honda, will be the first president of the new company.

The company said there will be no change in the distribution channel of Honda motorcycles and power products in Thailand for the time being.

Honda Wing Center network will still distribute Honda motorcycles while Honda BigWing network will serve customers with its big bikes (400cc or above). CUB House, the showroom for value-added products, will still run its business without any changes.

Do you like the content of this article?

The difficult search for truth at France's biggest terror trial

PARIS: During the nine-month trial stemming from France's worst ever terror attacks in November 2015, the moment hundreds of victims were hoping for came late in proceedings.


Cathay Pacific back on hiring spree in anticipation of take-off in global air travel

HONG KONG: When Jasmine Lau received an email from Cathay Pacific Airways last month asking if she wanted to return to her old job as a flight attendant, she contemplated the proposition, but eventually decided against applying.


China's Clover says its Covid booster shot candidate lifts antibody against Omicron

BEIJING: China's Clover Biopharmaceuticals said on Monday a booster shot of its Covid-19 vaccine candidate significantly increased antibody response against the Omicron coronavirus variant from levels seen after two primary shots.